You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Precision 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Contact Lens, Astigmatism of Both Eyes Trial in Columbus (Precision1® Daily Disposable Toric Contact Lens)

Active, not recruiting
  • Contact Lens
  • Astigmatism of Both Eyes
  • Precision1® Daily Disposable Toric Contact Lens
  • Columbus, Ohio
    The Ohio State University
Oct 13, 2022

Refractive Ametropia Trial in Rochester (Kalifilcon Toric Lens, Total1 for Astigmatism, Precision1 for Astigmatism)

Completed
  • Refractive Ametropia
  • Kalifilcon Toric Lens
  • +3 more
  • Rochester, New York
    Bausch & Lomb, Incorporated
Oct 23, 2023

Myopia Trial in Waterloo (Verafilcon A, Etafilcon A)

Suspended
  • Myopia
  • Verafilcon A
  • Etafilcon A
  • Waterloo, Ontario, Canada
    Centre for Ocular Research & Education
Feb 14, 2022

Astigmatism Trial in Houston (Precision1 for Astigmatism, Precision1 Sphere)

Completed
Has Results
  • Astigmatism
  • Precision1 for Astigmatism
  • Precision1 Sphere
  • Houston, Texas
    University of Houston College of Optometry
Feb 15, 2022

Type 2 Diabetes Trial in Hangzhou (White bread, Whole wheat bread, Plant-based diet)

Not yet recruiting
  • Type 2 Diabetes
  • White bread
  • +4 more
  • Hangzhou, Zhejiang, China
    Hangzhou Third People's Hospital
May 30, 2023

Habitual Soft Contact Lens Use Trial in Rochester (kalifilcon A lenses, Dalies Total 1, Precision 1)

Completed
Has Results
  • Habitual Soft Contact Lens Use
  • kalifilcon A lenses
  • +3 more
  • Rochester, New York
    Bausch and Lomb Site 01
Oct 8, 2021

Contact Lens Trial in Columbus (Biofinity® Monthly Replacement Contact Lens, Precision1® Daily Disposable Contact Lens)

Completed
  • Contact Lens
  • Biofinity® Monthly Replacement Contact Lens
  • Precision1® Daily Disposable Contact Lens
  • Columbus, Ohio
    The Ohio State University College of Optometry
Feb 17, 2022

Myopia Trial in Waterloo (Verofilcon A contact lenses)

Completed
  • Myopia
  • Verofilcon A contact lenses
  • Waterloo, Ontario, Canada
    Centre for Ocular Research & Education
Oct 1, 2021

Contact Lens Trial in Columbus (Biofinity Toric contact lenses, Precision1 for Astigmatism Daily Disposable contact lenses)

Active, not recruiting
  • Contact Lens
  • Biofinity Toric contact lenses
  • Precision1 for Astigmatism Daily Disposable contact lenses
  • Columbus, Ohio
    The Ohio State University College of Optometry
Oct 12, 2022

Diabetes, Pre Diabetes Trial in Orlando (Viome's Precision Nutrition Program (VPNP))

Recruiting
  • Diabetes
  • Pre Diabetes
  • Viome's Precision Nutrition Program (VPNP)
  • Orlando, Florida
    AdventHealth
Aug 2, 2022

Carcinoma, Solid Tumor Trial in Suzhou (ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin)

Not yet recruiting
  • Carcinoma
  • Solid Tumor
  • ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin
  • Suzhou, China
    Second Affiliated Hospital of Soochow University
Oct 26, 2023

Instrument Precision Study for Validation of PIPS 5.1

Recruiting
  • Pathology
  • PIPS 5.1
  • Silver Spring, Maryland
    Capital Choice Pathology Laboratory
May 12, 2022

Habitual Soft Contact Lens Use Trial in Rochester (Kalifon A, Dailies Total1, Precision1)

Completed
  • Habitual Soft Contact Lens Use
  • Kalifon A
  • +2 more
  • Rochester, New York
    Bausch Site 001
Jul 20, 2021

LabPatch Glucose Sensing System in Insulin-treated Diabetes

Recruiting
  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus
  • 2nd Gen LabPatch Glucose Sensing System
  • Boston, Massachusetts
    Joslin Diabetes Center
Feb 22, 2023

Topcon Pachymeter TRK-3 to Evaluate Agreement and Precision

Completed
  • Corneal Thickness
  • SP-1P
  • Tokyo, Japan
    Samoncho Clinic
Jul 19, 2022

Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

Recruiting
  • Neuroendocrine Tumor of Pancreas
  • Multiple Endocrine Neoplasia Type 1
  • High-dose-high precision MR-guided radiotherapy
  • Utrecht, Netherlands
    UMC Utrecht
May 29, 2022

NSCLC Patients Trial in Marseille (procedure, diagnostic test, other)

Recruiting
  • Non-small Cell Lung Cancer Patients
  • BIOPSY
  • +2 more
  • Marseille, France
    Assistance Pubique Hopitaux de Marseille
Sep 21, 2022

Myopia Trial in Waterloo (somofilcon A, verofilcon A)

Completed
Has Results
  • Myopia
  • somofilcon A
  • verofilcon A
  • Waterloo, Ontario, Canada
    University of Waterloo
Feb 10, 2022

NSCLC Trial in Marseille (Durvalumab (MEDI4736), Monalizumab (IPH2201), Oleclumab (MEDI9447))

Recruiting
  • Non-small Cell Lung Cancer
  • Durvalumab (MEDI4736)
  • +5 more
  • Marseille, France
    Assistance Publique Hopitaux de Marseille
Sep 21, 2022

Myopia, Ametropia Trial in United States (Verofilcon A contact lenses, Kalifilcon A contact lenses)

Completed
Has Results
  • Myopia
  • Ametropia
  • Verofilcon A contact lenses
  • Kalifilcon A contact lenses
  • Maitland, Florida
  • +3 more
Aug 16, 2022

OCT Agreement and Precision Study

Completed
  • Normal Eyes
  • +2 more
    • Jamaica, New York
      New York VA
    Jun 6, 2022

    Cardiovascular Risk Factor Trial in University Park (Digital message (text + image))

    Active, not recruiting
    • Cardiovascular Risk Factor
    • Digital message (text + image)
    • University Park, Pennsylvania
      The Pennsylvania State University
    Aug 8, 2022

    Astigmatism, Refractive Errors Trial in United States (Delefilcon A toric soft contact lens, Lehfilcon A toric soft contact

    Not yet recruiting
    • Astigmatism
    • Refractive Errors
    • Delefilcon A toric soft contact lens
    • +3 more
    • Los Angeles, California
    • +6 more
    Mar 23, 2023

    Clinical Utility of Oncomine Precision Assay Within Exactis

    Recruiting
    • NSCLC
      • Moncton, New Brunswick, Canada
      • +6 more
      Dec 9, 2022

      Wolfram Syndrome Trial (Tirzepatide)

      Not yet recruiting
      • Wolfram Syndrome
      • (no location specified)
      Dec 12, 2022